On March 2025, Roche stated that it has signed an exclusive collaboration and licensing deal with Zealand Pharma
Freedman DS, Butte NF, Taveras EM, Lundeen EA, Blanck HM, Goodman AB, et al
However, I feel strongly that people need to be informed about both the risks, benefits, and limitations of this (or any) medication that they use, which is part of the informed consent process between you and the prescribing professional
Some patients maintain more weight loss, especially those who made substantial lifestyle changes during treatment
Another study is testing how CagriSema works over longer periods and in people with higher body weights, with results expected around the first half of 2027
For bulk purchases where you are committing significant capital, third-party verification is not paranoia